Will Viking Therapeutics be acquired before 2027?
As of September 3, 2026, the market gives “Will Viking Therapeutics be acquired before 2027?” a 87% chance of NO.
| YES odds | 14% |
|---|---|
| NO odds | 87% |
| Volume | $1,703,434 |
| Closes | January 1, 2027 |
Updated September 3, 2026 · Live data from Polymarket
About this market
Strong M&A momentum in 2026, with global announced volumes up roughly 40% year-over-year in the first half to record levels around $3.1–3.2 trillion, has been propelled by megadeals exceeding $10 billion and AI-driven demand for scale in technology, data centers, power, and infrastructure. Strategic buyers are pursuing transformational acquisitions to secure capabilities amid competitive pressures, supported by a lighter regulatory environment, robust equity markets, and accessible financing despite persistent inflation and rate volatility. Cross-border activity has risen sharply, particularly in the Americas and EMEA, while sectors such as energy/utilities and healthcare have seen outsized gains. With several large announced transactions still pending and a constructive pipeline for the second half, trader focus centers on closing timelines, antitrust reviews, and macroeconomic stability through year-end.